These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3891350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
    Fukuda H, Matsuzawa T, Abe Y, Endo S, Yamada K, Kubota K, Hatazawa J, Sato T, Ito M, Takahashi T, Iwata R, Ido T.
    Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
    [Abstract] [Full Text] [Related]

  • 7. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
    Bøtker HE, Böttcher M, Schmitz O, Gee A, Hansen SB, Cold GE, Nielsen TT, Gjedde A.
    J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
    [Abstract] [Full Text] [Related]

  • 8. [18F]FDG in measuring myocardial glucose uptake.
    Knuuti J, Nuutila P, Voipio-Pulkki LM.
    Circulation; 1995 Nov 15; 92(10):3146-8. PubMed ID: 7586291
    [No Abstract] [Full Text] [Related]

  • 9. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose.
    Ding HJ, Shiau YC, Wang JJ, Ho ST, Kao A.
    Nucl Med Commun; 2002 Oct 15; 23(10):961-5. PubMed ID: 12352594
    [Abstract] [Full Text] [Related]

  • 10. Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.
    Gallagher BM, Ansari A, Atkins H, Casella V, Christman DR, Fowler JS, Ido T, MacGregor RR, Som P, Wan CN, Wolf AP, Kuhl DE, Reivich M.
    J Nucl Med; 1977 Oct 15; 18(10):990-6. PubMed ID: 903484
    [Abstract] [Full Text] [Related]

  • 11. Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
    Paul R, Roeda D, Johansson R, Ahonen A, Haaparanta M, Solin O, Sipilä H.
    Int J Rad Appl Instrum B; 1986 Oct 15; 13(1):7-12. PubMed ID: 3771240
    [Abstract] [Full Text] [Related]

  • 12. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
    Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N.
    Eur J Nucl Med; 2001 Jun 15; 28(6):730-5. PubMed ID: 11440033
    [Abstract] [Full Text] [Related]

  • 13. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
    Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo LI, Jones T, Maseri A, Yacoub MH.
    J Am Coll Cardiol; 1997 Aug 15; 30(2):533-8. PubMed ID: 9247529
    [Abstract] [Full Text] [Related]

  • 14. Simplified PET quantitation of myocardial glucose utilization.
    Nakagawa K, Namba H, Iyo M, Fukushi K, Irie T, Yamanouchi M, Shikama N, Himi T, Yoshida K, Masuda Y.
    J Nucl Med; 1995 Nov 15; 36(11):2094-102. PubMed ID: 7472605
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies.
    Suolinna EM, Haaparanta M, Paul R, Härkönen P, Solin O, Sipilä H.
    Int J Rad Appl Instrum B; 1986 Nov 15; 13(5):577-81. PubMed ID: 3818323
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism.
    Kearfott KJ, Elmaleh DR, Goodman M, Correia JA, Alpert NM, Ackerman RH, Brownell GL, Strauss WH.
    Int J Nucl Med Biol; 1984 Nov 15; 11(1):15-22. PubMed ID: 6610664
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of, and animal experiments with, N-isopropyl-p-123I-iodo-amphetamine (IMP) and 18F-3-deoxy-3-fluoro-D-glucose (3-FDG) as tracers in brain and heart diagnostic studies.
    Knust EJ, Machulla HJ, Baldwin RM, Chen T, Feinendegen LE.
    Nuklearmedizin; 1984 Feb 15; 23(1):31-4. PubMed ID: 6728691
    [Abstract] [Full Text] [Related]

  • 18. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y, Hawkins RA, Huang SC, Gambhir SS, Brunken RC, Phelps ME, Schelbert HR.
    J Nucl Med; 1991 Apr 15; 32(4):733-8. PubMed ID: 2013815
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK.
    J Nucl Med; 2001 Jan 15; 42(1):55-62. PubMed ID: 11197981
    [Abstract] [Full Text] [Related]

  • 20. Effect of steroids on [18F]fluorodeoxyglucose uptake in an experimental tumour model.
    Zhao S, Kuge Y, Nakada K, Mochizuki T, Takei T, Okada F, Tamaki N.
    Nucl Med Commun; 2004 Jul 15; 25(7):727-30. PubMed ID: 15208501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.